Ubs Group Ag Zymergen Inc. Transaction History

Ubs Group Ag

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$1.2 - $3.37 $23,772 - $66,759	19,810 Added 300.33%	26,406 $73,000
Q2 2022 Aug 10, 2022	SELL	$1.12 - $3.03 $12,629 - $34,166	-11,276 Reduced 63.09%	6,596 $8,000
Q1 2022 May 16, 2022	SELL	$2.88 - $7.02 $193,060 - $470,585	-67,035 Reduced 78.95%	17,872 $51,000
Q4 2021 Feb 14, 2022	BUY	$6.53 - $14.19 $464,909 - $1.01 Million	71,196 Added 519.26%	84,907 $568,000
Q3 2021 Nov 15, 2021	SELL	$8.25 - $41.0 $278,000 - $1.38 Million	-33,697 Reduced 71.08%	13,711 $181,000
Q2 2021 Aug 13, 2021	BUY	$28.5 - $48.5 $1.35 Million - $2.3 Million	47,408 New	47,408 $1.9 Million

5.49M

Ticker ZY
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 104,355,000
Market Cap $254M
Description
Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to co...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.